Hasegawa M et al. |
Diagnostic criteria, severity classification and guidelines of lichen sclerosus et atrophicus. |
2018 |
J. Dermatol. |
pmid:29265410
|
Gómez-Bravo MA et al. |
Influence of donor liver CYP3A4*20 loss-of-function genotype on tacrolimus pharmacokinetics in transplanted patients. |
2018 |
Pharmacogenet. Genomics |
pmid:29256966
|
Motta A et al. |
Immunohistopathological characterization and the impact of topical immunomodulatory therapy in oral chronic graft-versus-host disease: A pilot study. |
2018 |
Oral Dis |
pmid:29197137
|
Leiskau C et al. |
Side effects and efficacy of renal sparing immunosuppression in pediatric liver transplantation-A single center matched cohort study. |
2018 |
Pediatr Transplant |
pmid:29729061
|
Shuker N et al. |
Intrapatient Variability in Tacrolimus Exposure Does Not Predict The Development of Cardiac Allograft Vasculopathy After Heart Transplant. |
2018 |
Exp Clin Transplant |
pmid:28969528
|
Bae SC and Lee YH |
Comparative efficacy and tolerability of monotherapy with leflunomide or tacrolimus for the treatment of rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials. |
2018 |
Clin. Rheumatol. |
pmid:28967035
|
Zhang H et al. |
Prediction of Drug-Drug Interaction between Tacrolimus and Principal Ingredients of Wuzhi Capsule in Chinese Healthy Volunteers Using Physiologically-Based Pharmacokinetic Modelling. |
2018 |
Basic Clin. Pharmacol. Toxicol. |
pmid:28945011
|
Al-Lawati H et al. |
Nanomedicine for immunosuppressive therapy: achievements in pre-clinical and clinical research. |
2018 |
Expert Opin Drug Deliv |
pmid:29261332
|
Park CS et al. |
Tetrahydrocurcumin Ameliorates Tacrolimus-Induced Nephrotoxicity Via Inhibiting Apoptosis. |
2018 |
Transplant. Proc. |
pmid:30401411
|
Kaneko T et al. |
Comparison of whole-blood tacrolimus concentrations measured by different immunoassay systems. |
2018 |
J. Clin. Lab. Anal. |
pmid:29974517
|
Lee KH et al. |
Distribution of Anti-ABO Immunoglobulin G Subclass and C1q Antibody in ABO-incompatible Kidney Transplantation. |
2018 |
Transplant. Proc. |
pmid:29731066
|
Htun YY et al. |
CYP3A5*3 Genetic Polymorphism and Tacrolimus Concentration in Myanmar Renal Transplant Patients. |
2018 |
Transplant. Proc. |
pmid:29731062
|
Hu R et al. |
CYP3A5*3 and ABCB1 61A>G Significantly Influence Dose-adjusted Trough Blood Tacrolimus Concentrations in the First Three Months Post-Kidney Transplantation. |
2018 |
Basic Clin. Pharmacol. Toxicol. |
pmid:29603629
|
Mücke VT et al. |
Low Serum Levels of (Dihydro-)Ceramides Reflect Liver Graft Dysfunction in a Real-World Cohort of Patients Post Liver Transplantation. |
2018 |
Int J Mol Sci |
pmid:29587453
|
Cintra-Cabrera M et al. |
Resistant Cytomegalovirus Infection After Renal Transplantation: Literature Review. |
2018 |
Transplant. Proc. |
pmid:29579856
|
Davidson HE |
Shifting Paradigms in Caring for Older Adults. |
2018 |
Consult Pharm |
pmid:29789044
|
Jouve T et al. |
Tailoring tacrolimus therapy in kidney transplantation. |
2018 |
Expert Rev Clin Pharmacol |
pmid:29779413
|
Pircher C et al. |
A rare case of Epstein-Barr virus-associated hepatosplenic smooth muscle tumors after kidney transplantation. |
2018 |
Transpl Infect Dis |
pmid:29427352
|
Yang Y et al. |
Chlormethine Hydrochloride is Not Inferior to Tacrolimus in Treating Steroid-Resistant Nephrotic Syndrome. |
2018 |
Kidney Blood Press. Res. |
pmid:29402844
|
Murad A et al. |
Primary cutaneous post liver transplant lymphoproliferative disorder (PTLD) successfully treated with radiotherapy. |
2018 |
J Dermatolog Treat |
pmid:28604230
|